store at low temperature
store at -80°C
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22. Inotuzumab is a naked antibody to Inotuzumab ozogamicin and can be used to synthesize antibody-active molecule conjugators (Inotuzumab ozogamicin). Inotuzumab can be used to study acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 289.00 | |
5 mg | In stock | $ 726.00 | |
10 mg | In stock | $ 1,160.00 | |
25 mg | In stock | $ 1,720.00 | |
50 mg | In stock | $ 2,290.00 | |
100 mg | In stock | $ 3,120.00 |
Description | Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22. Inotuzumab is a naked antibody to Inotuzumab ozogamicin and can be used to synthesize antibody-active molecule conjugators (Inotuzumab ozogamicin). Inotuzumab can be used to study acute lymphoblastic leukemia and non-Hodgkin's lymphoma. |
Molecular Weight | N/A |
CAS No. | 1660159-36-3 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Inotuzumab 1660159-36-3 Others inhibitor inhibit